{"schema_version":"1","generated_at":"2026-11-10T18:40:37.194Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jeffrey-shevach","json_url":"https://www.findmykol.com/kol/jeffrey-shevach/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jeffrey-shevach","name":"Jeffrey Shevach","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Duke University","institution_url":"https://www.findmykol.com/institution/duke-university","city":"Durham","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1225579667","orcid":"0000-0002-3982-781X","openalex":"A5067933558"},"summary":"Jeffrey Shevach is an Oncology physician affiliated with Duke University. OpenAlex indexes 37 publications with 233 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":37,"cited_by_count":233,"h_index":10,"latest_activity_year":2026,"emerging":true,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"AstraZeneca","program_year":2025,"amount_usd":112150.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225579667"},{"payer":"Merck & Co.","program_year":2025,"amount_usd":68522.71,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225579667"},{"payer":"Merck & Co.","program_year":2024,"amount_usd":65592.16,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225579667"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1225579667","source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":37,"shown":5,"withheld":32,"matched_by":"OpenAlex author record","recent":[{"title":"Phase 2 multicenter trial of chemoimmunotherapy for patients with neuroendocrine or aggressive variant metastatic prostate cancer (CHAMP).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.5016","status":"verified"},{"title":"Clinical and genomic predictors of sipuleucel-T (sip-T) outcomes in men with metastatic castration-resistant prostate cancer (mCRPC).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.228","status":"verified"},{"title":"21 A Phase II Study of Total Consolidative Metastasis-and-Primary Directed Therapy for Renal Cell Carcinoma (NCT06770855)","year":2026,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyag312.022","status":"verified"},{"title":"Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer","year":2026,"journal":"Prostate Cancer and Prostatic Diseases","source_url":"https://doi.org/10.1038/s41391-026-01145-0","status":"verified"},{"title":"Proper Phenotyping of Pancreatic Cancer in Database Research","year":2026,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2026.2609","status":"verified"}],"source":"works"},"similar":[{"name":"Pamela Douglas","slug":"pamela-douglas","institution":"Duke University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/pamela-douglas","json_url":"https://www.findmykol.com/kol/pamela-douglas/profile.json"},{"name":"Adrian Hernandez","slug":"adrian-hernandez","institution":"Duke University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/adrian-hernandez","json_url":"https://www.findmykol.com/kol/adrian-hernandez/profile.json"},{"name":"Scott Antonia","slug":"scott-antonia","institution":"Duke University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/scott-antonia","json_url":"https://www.findmykol.com/kol/scott-antonia/profile.json"},{"name":"Jonathan Piccini","slug":"jonathan-piccini","institution":"Duke University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/jonathan-piccini","json_url":"https://www.findmykol.com/kol/jonathan-piccini/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":32}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}